节段性异时性腺瘤率用于监测结肠镜筛查中息肉不完全切除
该研究通过计算节段性异时性腺瘤率(SMAR-IR)比较6-9mm与10-20mm管状腺瘤不完全切除的贡献。337例患者中,10-20mm腺瘤的SMAR-IR为11.4%(95%CI 4.5-18.3),6-9mm腺瘤的SMAR-IR为13.2%(95%CI 7.2-19.4)。6名结肠镜医师的SMAR-IR在7.0%-15.5%之间,提示6-9mm病变不完全切除也是异时性肿瘤的重要风险因素。
要点
- 6-9mm管状腺瘤不完全切除的SMAR-IR为13.2%,不低于10-20mm腺瘤的11.4%。
- 6名结肠镜医师的SMAR-IR范围为7.0%-15.5%,可用于监测息肉切除质量。
- 6-9mm病变的不完全切除同样是异时性肿瘤的显著风险因素。
核心结论
- 有10-20mm或6-9mm管状腺瘤的节段异时性肿瘤率高于无腺瘤节段,不完全切除是6-9mm及更大病变异时性肿瘤的重要风险因素。
研究设计与样本
- 研究纳入337例患者,其中146例索引结肠镜最大病变为10-20mm管状腺瘤,191例为6-9mm管状腺瘤。
- 通过有腺瘤节段与无腺瘤节段的异时性肿瘤率差值计算节段性异时性腺瘤率(SMAR-IR)。
主要发现
- 10-20mm管状腺瘤病例:有腺瘤节段SMAR为21.0%,无腺瘤节段为9.6%,SMAR-IR为11.4%(95%CI 4.5-18.3)。
- 6-9mm管状腺瘤病例:有腺瘤节段SMAR为22.0%,无腺瘤节段为8.8%,SMAR-IR为13.2%(95%CI 7.2-19.4)。
- 6名结肠镜医师对6-20mm息肉的SMAR-IR范围为7.0%-15.5%。
关键数值与推荐
- 10-20mm管状腺瘤的SMAR-IR为11.4%(95%CI 4.5-18.3)。
- 6-9mm管状腺瘤的SMAR-IR为13.2%(95%CI 7.2-19.4)。
- 6名结肠镜医师的SMAR-IR介于7.0%和15.5%之间。
临床怎么用
- 可将SMAR-IR作为监测结肠镜医师息肉切除质量的指标,尤其应关注6-9mm病变的不完全切除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Polypectomy technique has been shown to vary among colonoscopists, and interval colorectal cancer may result from incomplete resection of an adenoma. Methods to monitor polypectomy quality and the size of polyps resected to monitor have not been well defined. The aim of this study was to compare the rate of metachronous adenoma attributable to incomplete resection in polyps 6 to 9 mm versus polyps 10 to 20 mm. METHODS: The segmental metachronous adenoma rate attributable to incomplete resection (SMAR-IR) was calculated by subtracting the rate of metachronous neoplasia (MN) in segments without adenoma from segments with adenoma. The primary outcome of the study was the SMAR-IR in polyps 6 to 9 mm and 10 to 20 mm found on index colonoscopy. RESULTS: Of 337 patients included in the analysis, 146 patients had a tubular adenoma (TA) 10 to 20 mm in size and 191 patients a TA 6 to 9 mm in size as the most advanced lesion. For cases in which an index 10- to 20-mm TA was resected, the SMAR in segments with adenoma was 21.0% and in segments without adenoma 9.6%, so the SMAR-IR was 11.4% (95% confidence interval, 4.5-18.3). For cases in which an index 6- to 9-mm TA was resected, the SMAR in segments with adenoma was 22.0% and in segments without adenoma 8.8%, so the SMAR-IR was 13.2% (95% confidence interval, 7.2-19.4). Among 6 colonoscopists, the SMAR-IR ranged between 7.0% and 15.5% for polyps 6 to 20 mm. CONCLUSIONS: MN rates in segments with a TA 10-20 mm and a TA 6-9 mm are higher than the MN rates in segments without index neoplasia. Incomplete resection of neoplasia appears to be a significant risk factor for MN in 6- to 9-mm lesions as well as larger ones.
引用
- Alsayid M, Van J, Ma K, et al. Segmental metachronous adenoma rate as a metric for monitoring incomplete resection in a colonoscopy screening program. Gastrointest Endosc. 2021. PMID: 33561485. doi:10.1016/j.gie.2021.01.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。